muscalure: sex sttractant pheromone of housefly with formula C24H48, alkene hydrocarbon; RN given refers to cpd with unspecified stereochemistry; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| ID Source | ID |
|---|---|
| PubMed CID | 5365075 |
| CHEMBL ID | 1894305 |
| CHEBI ID | 194482 |
| MeSH ID | M0044712 |
| Synonym |
|---|
| 9-tricosene, (z)- |
| (z)-9-tricosene |
| (z)-9-tricosene, 97% |
| NCGC00163763-01 |
| brn 1841622 |
| einecs 248-505-7 |
| caswell no. 883c |
| ai3-35349 |
| muscalure |
| 9-tricosene, (9z)- |
| muscamone |
| ent 35349 |
| epa pesticide chemical code 103201 |
| cis-tricos-9-ene |
| cis-9-tricosene , |
| 27519-02-4 |
| z-9-tricosene |
| T1242 |
| CHEBI:194482 |
| (z)-tricos-9-ene |
| 9z-tricosene |
| LMFA11000117 |
| A819098 |
| unii-6bsp6hfw73 |
| 6bsp6hfw73 , |
| AM84868 |
| tricosene, z-9- |
| muscalure [mi] |
| (9z)-9-tricosene |
| (9z)-9-tricosene # |
| CHEMBL1894305 |
| (9z)-tricosene |
| (9z)-tricos-9-ene |
| AKOS024462408 |
| DTXSID0032653 |
| muscalure, pestanal(r), analytical standard |
| J-016797 |
| AS-14813 |
| Q135445 |
| 9z-tricosene cas 27519-02-4 |
| PD057642 |
| HY-W009165 |
| CS-W009881 |
| Class | Description |
|---|---|
| tricosene | An alkene that is tricosane carrying 1 double bond (the position of the double bond is unspecified). |
| [compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] | |
| Pathway | Proteins | Compounds |
|---|---|---|
| (Z)-9-tricosene biosynthesis | 0 | 10 |
| Protein | Taxonomy | Measurement | Average (µ) | Min (ref.) | Avg (ref.) | Max (ref.) | Bioassay(s) |
|---|---|---|---|---|---|---|---|
| farnesoid X nuclear receptor | Homo sapiens (human) | Potency | 0.0010 | 0.3758 | 27.4851 | 61.6524 | AID588527 |
| vitamin D (1,25- dihydroxyvitamin D3) receptor | Homo sapiens (human) | Potency | 0.0014 | 0.0237 | 23.2282 | 63.5986 | AID588543 |
| thyroid hormone receptor beta isoform a | Homo sapiens (human) | Potency | 44.6684 | 0.0100 | 39.5371 | 1,122.0200 | AID588547 |
| [prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] | |||||||
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 3 (16.67) | 18.7374 |
| 1990's | 6 (33.33) | 18.2507 |
| 2000's | 3 (16.67) | 29.6817 |
| 2010's | 6 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.
| This Compound (35.09) All Compounds (24.57) |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 18 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||